Bank Julius Baer & Co. Ltd, Zurich Cybin Inc. Call Options Transaction History
Bank Julius Baer & Co. Ltd, Zurich
- $25.6 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYBN
# of Institutions
10Shares Held
185KCall Options Held
0Put Options Held
0-
Virtu Financial LLC New York, NY118KShares$1.25 Million0.0% of portfolio
-
Emfo, LLC24.5KShares$259,4350.01% of portfolio
-
Unique Wealth Strategies, LLC Burr Ridge, IL12.7KShares$134,5140.0% of portfolio
-
Victory Financial Group, LLC Austin, TX11.7KShares$124,1360.0% of portfolio
-
Covington Capital Management10KShares$106,0000.0% of portfolio
About CYBIN INC.
- Ticker CYBN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 166,120,000
- Market Cap $1.76B
- Description
- Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...